Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

David D. Waters, Jacques Lespérance, Peter Gladstone et al.|Circulation|1994

Cited by 505